Profound Medical Corp (PRN.TO)
10.61
+0.06
(+0.57%)
CAD |
TSX |
Nov 22, 16:00
Profound Medical Shareholders Equity (Quarterly): 41.96M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 41.96M |
| June 30, 2024 | 53.73M |
| March 31, 2024 | 62.09M |
| December 31, 2023 | 41.35M |
| September 30, 2023 | 52.40M |
| June 30, 2023 | 58.78M |
| March 31, 2023 | 65.90M |
| December 31, 2022 | 70.55M |
| September 30, 2022 | 82.21M |
| June 30, 2022 | 87.45M |
| March 31, 2022 | 92.95M |
| December 31, 2021 | 102.74M |
| September 30, 2021 | 112.25M |
| June 30, 2021 | 111.42M |
| March 31, 2021 | 117.92M |
| December 31, 2020 | 124.13M |
| September 30, 2020 | 124.50M |
| June 30, 2020 | 69.49M |
| March 31, 2020 | 75.17M |
| December 31, 2019 | 18.77M |
| Date | Value |
|---|---|
| September 30, 2019 | 23.29M |
| June 30, 2019 | 18.37M |
| March 31, 2019 | 23.88M |
| December 31, 2018 | 26.63M |
| September 30, 2018 | 31.10M |
| June 30, 2018 | 36.29M |
| March 31, 2018 | 41.60M |
| December 31, 2017 | 14.14M |
| September 30, 2017 | 18.43M |
| June 30, 2017 | 6.618M |
| March 31, 2017 | 10.83M |
| December 31, 2016 | 14.88M |
| September 30, 2016 | 2.921M |
| June 30, 2016 | 6.846M |
| March 31, 2016 | 10.33M |
| December 31, 2015 | 13.96M |
| September 30, 2015 | 16.65M |
| June 30, 2015 | 19.34M |
| March 31, 2015 | 1.536M |
| September 30, 2014 | 1.776M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
18.77M
Minimum
Dec 2019
124.50M
Maximum
Sep 2020
78.29M
Average
72.86M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biocure Technology Inc | 1.559M |
| Core One Labs Inc | 5.641M |
| Restart Life Sciences Corp | -1.046M |
| Nanosphere Health Sciences Inc | -2.231M |
| Lobe Sciences Ltd | -1.113M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 57.05M |
| Total Liabilities (Quarterly) | 15.09M |
| Debt to Equity Ratio | 0.1802 |
| Current Ratio | 6.123 |
| Net Debt Paydown Yield | 0.16% |